All Posts Tagged Tag: ‘LDL’

Cholesterol Drug by Amgen Cuts LDL by 60%

A new class of experimental drugs have been proven to dramatically lower cholesterol, and may become a viable option for the 70 million Americans who have high LDL (low-density lipoprotein) or “bad” cholesterol. One of these new medicines, Amgen’s Evolocumab, cut cholesterol by 55 to 66 percent compared to a placebo in some studies. The new cholesterol drugs might serve …

Read More

Cholesterol, New Drug May Bring Billions In Revenue

Sanofi and Regeneron have come together to create a drug that lowers cholesterol and allows people more choices with monitoring individual cholesterol levels. The drug has the potential to sweep through the medial world with current projections aiming that the drug may provide a $3 billion industry by itself. The new drug, alirocumab, is a PCSK9 inhibitor. But what does …

Read More